Author

Matteo Gozzi

University of Münster

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:protein structure· 1 Approach:simulation· 1

Frequent Co-Authors

Joana MassaiD· 2 shared Oliver KochiD· 2 shared Albrecht SchwabiD· 1 shared Bjoern Bengt BurckhardtiD· 1 shared Etmar Bulk· 1 shared Jurek HenseiD· 1 shared Martina DüferiD· 1 shared Tanja GangnusiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Joana MassaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters KCa2.2 vs KCa3.1 Ligand Selectivity

Matteo Gozzi, Joana Massa, Oliver Koch

This study identifies Ser353/Pro245 as the key structural determinant for ligand selectivity differences between KCa2.2 and KCa3.1 channels using computational methods.

Archiv der Pharmazie · Jul 1, 2026Peer-reviewedPharmacology & Toxicology

Discovery of the first small-molecule extracellular inhibitor of KCa3.1

Joana Massa, Jurek Hense, Tanja Gangnus, Matteo Gozzi, Etmar Bulk, Bjoern Bengt Burckhardt, Martina Düfer, Albrecht Schwab, Oliver Koch

This paper discovers a small-molecule inhibitor of KCa3.1 channels by combining molecular dynamics simulations and high-throughput screening.

bioRxiv · Mar 10, 2026 · PreprintPharmacology & Toxicology